Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Penumbra Inc (PEN)

Penumbra Inc (PEN)
250.62 -7.19 (-2.79%) 01/10/25 [NYSE]
248.50 x 100 255.00 x 700
Realtime by (Cboe BZX)
248.50 x 100 255.00 x 700
Realtime 250.62 unch (unch) 01/10/25
Profile for Fri, Jan 10th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Penumbra Inc One Penumbra Place Alameda CA 94502 USA

www.penumbrainc.com Employees: 4,200 P: 510-748-3200

Description:

Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.

Key Statistics

Overview:

Market Capitalization, $K 9,618,545
Enterprise Value, $K 9,451,055
Shares Outstanding, K 38,379
Annual Sales, $ 1,059 M
Annual Net Income, $ 90,950 K
Last Quarter Sales, $ 301,040 K
Last Quarter Net Income, $ 29,530 K
EBIT, $ 1,530 K
EBITDA, $ 28,790 K
60-Month Beta 0.52
% of Insider Shareholders 5.00%
% of Institutional Shareholders 88.88%
Float, K 36,460
% Float 95.00%
Short Volume Ratio 0.58

Growth:

1-Year Return 0.30%
3-Year Return 5.49%
5-Year Return 56.29%
5-Year Revenue Growth 137.90%
5-Year Earnings Growth 309.80%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.85 on 10/30/24
Next Earnings Date 02/27/25
Earnings Per Share ttm 2.66
EPS Growth vs. Prev Qtr 32.81%
EPS Growth vs. Prev Year 26.87%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

PEN Ratios

Ratio
Price/Earnings ttm 96.92
Price/Earnings forward 66.76
Price/Earnings to Growth 1.89
Return-on-Equity % 8.99%
Return-on-Assets % 6.80%
Profit Margin % 8.59%
Debt/Equity 0.00
Price/Sales 8.37
Price/Cash Flow 91.17
Price/Book 8.96
Book Value/Share 28.77
Interest Coverage -1.16
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Trading Volume: The most powerful technical indicator in the world